Macrogenics Stock Investor Sentiment
| MGNX Stock | USD 3.21 0.07 2.13% |
Slightly above 68% of MacroGenics' investor base is looking to short. The analysis of the overall investor sentiment regarding MacroGenics suggests that many traders are alarmed. MacroGenics' investing sentiment can be driven by a variety of factors including economic data, MacroGenics' earnings reports, geopolitical events, and overall market trends.
MacroGenics |
MacroGenics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. That information is available publicly through MacroGenics media outlets and privately through word of mouth or via MacroGenics internal channels. However, regardless of the origin, that massive amount of MacroGenics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.
MacroGenics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | MacroGenics, Inc. Class Action Levi Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, ... | 09/17/2024 |
2 | Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. Lawsuit - MGNX | 09/19/2024 |
3 | Acquisition by Koenig Scott of 374215 shares of MacroGenics subject to Rule 16b-3 | 09/23/2024 |
4 | Disposition of 53265 shares by Koenig Scott of MacroGenics subject to Rule 16b-3 | 10/07/2024 |
5 | MacroGenics sells breast cancer treatment to TerSera | 10/22/2024 |
6 | Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders MGNX Stock News - StockTitan | 10/25/2024 |
7 | Earnings To Watch Macrogenics Inc Reports Q3 2024 Result | 11/04/2024 |
8 | MacroGenics GAAP EPS of 0.90 beats by 0.81, revenue of 110.7M beats by 23.12M | 11/05/2024 |
9 | Heres What Key Metrics Tell Us About MacroGenics Q3 Earnings | 11/06/2024 |
10 | MacroGenics, Inc. Q2 2024 Earnings Call Transcript | 11/07/2024 |
11 | ARMISTICE CAPITAL, LLC Acquires Significant Stake in Macrogenics Inc | 11/15/2024 |
Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.